Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Vasovagal Syncope Prevention (POST 11)
NCT05755737Phase 2Recruiting
- Sponsor
- University of Calgary
- Start
- Jun 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ondansetron in vasovagal syncope, sponsored by University of Calgary. Started Jun 2023; status: recruiting.
02
Drugs
ondansetron
03
Conditions
vasovagal syncope
Beyond the preview
Go deeper on NCT05755737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05755737.